N-Desmethyl Regorafenib N-oxide, an active metabolite of the multi-kinase inhibitor regorafenib, originates through the action of the cytochrome P450 (CYP) isoform CYP3A4. This compound demonstrates efficacy in vitro by inhibiting key enzymes such as VEGFR2, Tie2, c-Kit, and B-RAF, and it exhibits tumor growth inhibition in HT-29 and MDA-MB-231 mouse xenograft models at a dosage of 1 mg/kg.
Marketplace OffersShowing from 1 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
35 days
Purity
-
$ 86.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.